| Procedural characteristic . | Fasting (N = 358) . | No fasting (N = 358) . |
|---|---|---|
| In-patient procedure, n/total n (%) | 122/358 (34.1) | 125/358 (34.9) |
| Procedure type | ||
| Percutaneous coronary procedure, n/total n (%) | 297/358 (83.0) | 306/358 (85.5) |
| Radial access attempted, n/total n (%) | 288/297 (97) | 293/304 (95.7) |
| Femoral access attempted, n/total n (%) | 17/297 (5.7) | 18/304 (5.9) |
| Diagnostic, n/total n (%) | 207/297 (69.7) | 193/306 (63.1) |
| Coronary intervention,a n/total n (%) | 90/297 (30.3) | 113/306 (36.9) |
| Physiology assessment, n/total n (%) | 19/297 (6.4) | 29/306 (9.5) |
| Coronary stent/balloon, n/total n (%) | 72/297 (24.2) | 83/306 (27.1) |
| Number of stents | 1.4 ± .7 | 1.4 ± .7 |
| Left main intervention | 2/72 (2.8) | 5/83 (6.0) |
| Left anterior descending artery | 31/72 (43.1) | 39/83 (47.0) |
| Right/circumflex artery | 44/72 (61.1) | 51/83 (61.4) |
| Graft intervention | 1/72 (1.4) | 3/83 (3.6) |
| Unplanned calcium modification | 0/72 (0) | 2/83 (2.4) |
| Device procedure, n/total n (%) | 61/358 (17.0) | 52/358 (14.5) |
| Pacemaker, n/total n (%) | 40/61 (65.6) | 28/52 (53.8) |
| Defibrillator, n/total n (%) | 9/61 (14.8) | 4/52 (7.8) |
| Lead revision, n/total n (%) | 5/61 (8.2) | 2/52 (3.8) |
| Generator change, n/total n (%) | 7/61 (11.5) | 18/52 (34.6) |
| Sedation provision | 311/358 (87) | 318/358 (89) |
| Midazolam (mg), mean ± SD | 1.3 ± .75 | 1.2 ± .5 |
| Fentanyl (µg), mean ± SD | 40.3 ± 20.4 | 41.3 ± 24.4 |
| Fasting times | ||
| Solid food fasting time (IQR) | 13.2 (8.5–15.1) | 3.0 (1.8–4.2) |
| Clear liquid fasting time (IQR) | 7.0 (4.2–12.1) | 2.4 (1.2–3.5) |
| Procedural characteristic . | Fasting (N = 358) . | No fasting (N = 358) . |
|---|---|---|
| In-patient procedure, n/total n (%) | 122/358 (34.1) | 125/358 (34.9) |
| Procedure type | ||
| Percutaneous coronary procedure, n/total n (%) | 297/358 (83.0) | 306/358 (85.5) |
| Radial access attempted, n/total n (%) | 288/297 (97) | 293/304 (95.7) |
| Femoral access attempted, n/total n (%) | 17/297 (5.7) | 18/304 (5.9) |
| Diagnostic, n/total n (%) | 207/297 (69.7) | 193/306 (63.1) |
| Coronary intervention,a n/total n (%) | 90/297 (30.3) | 113/306 (36.9) |
| Physiology assessment, n/total n (%) | 19/297 (6.4) | 29/306 (9.5) |
| Coronary stent/balloon, n/total n (%) | 72/297 (24.2) | 83/306 (27.1) |
| Number of stents | 1.4 ± .7 | 1.4 ± .7 |
| Left main intervention | 2/72 (2.8) | 5/83 (6.0) |
| Left anterior descending artery | 31/72 (43.1) | 39/83 (47.0) |
| Right/circumflex artery | 44/72 (61.1) | 51/83 (61.4) |
| Graft intervention | 1/72 (1.4) | 3/83 (3.6) |
| Unplanned calcium modification | 0/72 (0) | 2/83 (2.4) |
| Device procedure, n/total n (%) | 61/358 (17.0) | 52/358 (14.5) |
| Pacemaker, n/total n (%) | 40/61 (65.6) | 28/52 (53.8) |
| Defibrillator, n/total n (%) | 9/61 (14.8) | 4/52 (7.8) |
| Lead revision, n/total n (%) | 5/61 (8.2) | 2/52 (3.8) |
| Generator change, n/total n (%) | 7/61 (11.5) | 18/52 (34.6) |
| Sedation provision | 311/358 (87) | 318/358 (89) |
| Midazolam (mg), mean ± SD | 1.3 ± .75 | 1.2 ± .5 |
| Fentanyl (µg), mean ± SD | 40.3 ± 20.4 | 41.3 ± 24.4 |
| Fasting times | ||
| Solid food fasting time (IQR) | 13.2 (8.5–15.1) | 3.0 (1.8–4.2) |
| Clear liquid fasting time (IQR) | 7.0 (4.2–12.1) | 2.4 (1.2–3.5) |
IQR, median with interquartile range; SD, standard deviation.
aCoronary intervention includes physiologic assessment, stenting, and plain old balloon angioplasty.
| Procedural characteristic . | Fasting (N = 358) . | No fasting (N = 358) . |
|---|---|---|
| In-patient procedure, n/total n (%) | 122/358 (34.1) | 125/358 (34.9) |
| Procedure type | ||
| Percutaneous coronary procedure, n/total n (%) | 297/358 (83.0) | 306/358 (85.5) |
| Radial access attempted, n/total n (%) | 288/297 (97) | 293/304 (95.7) |
| Femoral access attempted, n/total n (%) | 17/297 (5.7) | 18/304 (5.9) |
| Diagnostic, n/total n (%) | 207/297 (69.7) | 193/306 (63.1) |
| Coronary intervention,a n/total n (%) | 90/297 (30.3) | 113/306 (36.9) |
| Physiology assessment, n/total n (%) | 19/297 (6.4) | 29/306 (9.5) |
| Coronary stent/balloon, n/total n (%) | 72/297 (24.2) | 83/306 (27.1) |
| Number of stents | 1.4 ± .7 | 1.4 ± .7 |
| Left main intervention | 2/72 (2.8) | 5/83 (6.0) |
| Left anterior descending artery | 31/72 (43.1) | 39/83 (47.0) |
| Right/circumflex artery | 44/72 (61.1) | 51/83 (61.4) |
| Graft intervention | 1/72 (1.4) | 3/83 (3.6) |
| Unplanned calcium modification | 0/72 (0) | 2/83 (2.4) |
| Device procedure, n/total n (%) | 61/358 (17.0) | 52/358 (14.5) |
| Pacemaker, n/total n (%) | 40/61 (65.6) | 28/52 (53.8) |
| Defibrillator, n/total n (%) | 9/61 (14.8) | 4/52 (7.8) |
| Lead revision, n/total n (%) | 5/61 (8.2) | 2/52 (3.8) |
| Generator change, n/total n (%) | 7/61 (11.5) | 18/52 (34.6) |
| Sedation provision | 311/358 (87) | 318/358 (89) |
| Midazolam (mg), mean ± SD | 1.3 ± .75 | 1.2 ± .5 |
| Fentanyl (µg), mean ± SD | 40.3 ± 20.4 | 41.3 ± 24.4 |
| Fasting times | ||
| Solid food fasting time (IQR) | 13.2 (8.5–15.1) | 3.0 (1.8–4.2) |
| Clear liquid fasting time (IQR) | 7.0 (4.2–12.1) | 2.4 (1.2–3.5) |
| Procedural characteristic . | Fasting (N = 358) . | No fasting (N = 358) . |
|---|---|---|
| In-patient procedure, n/total n (%) | 122/358 (34.1) | 125/358 (34.9) |
| Procedure type | ||
| Percutaneous coronary procedure, n/total n (%) | 297/358 (83.0) | 306/358 (85.5) |
| Radial access attempted, n/total n (%) | 288/297 (97) | 293/304 (95.7) |
| Femoral access attempted, n/total n (%) | 17/297 (5.7) | 18/304 (5.9) |
| Diagnostic, n/total n (%) | 207/297 (69.7) | 193/306 (63.1) |
| Coronary intervention,a n/total n (%) | 90/297 (30.3) | 113/306 (36.9) |
| Physiology assessment, n/total n (%) | 19/297 (6.4) | 29/306 (9.5) |
| Coronary stent/balloon, n/total n (%) | 72/297 (24.2) | 83/306 (27.1) |
| Number of stents | 1.4 ± .7 | 1.4 ± .7 |
| Left main intervention | 2/72 (2.8) | 5/83 (6.0) |
| Left anterior descending artery | 31/72 (43.1) | 39/83 (47.0) |
| Right/circumflex artery | 44/72 (61.1) | 51/83 (61.4) |
| Graft intervention | 1/72 (1.4) | 3/83 (3.6) |
| Unplanned calcium modification | 0/72 (0) | 2/83 (2.4) |
| Device procedure, n/total n (%) | 61/358 (17.0) | 52/358 (14.5) |
| Pacemaker, n/total n (%) | 40/61 (65.6) | 28/52 (53.8) |
| Defibrillator, n/total n (%) | 9/61 (14.8) | 4/52 (7.8) |
| Lead revision, n/total n (%) | 5/61 (8.2) | 2/52 (3.8) |
| Generator change, n/total n (%) | 7/61 (11.5) | 18/52 (34.6) |
| Sedation provision | 311/358 (87) | 318/358 (89) |
| Midazolam (mg), mean ± SD | 1.3 ± .75 | 1.2 ± .5 |
| Fentanyl (µg), mean ± SD | 40.3 ± 20.4 | 41.3 ± 24.4 |
| Fasting times | ||
| Solid food fasting time (IQR) | 13.2 (8.5–15.1) | 3.0 (1.8–4.2) |
| Clear liquid fasting time (IQR) | 7.0 (4.2–12.1) | 2.4 (1.2–3.5) |
IQR, median with interquartile range; SD, standard deviation.
aCoronary intervention includes physiologic assessment, stenting, and plain old balloon angioplasty.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
